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Abstract Enforced restrictions on the use of antibiotics as
growth promoters (AGPs) in animal production have
prompted investigations into alternative feed additives in re-
cent decades. Probiotics are currently the main feed additive
used in livestock. However, the selection of probiotic candi-
dates relies on human-basedmethods and little is known about
the verification criteria for host-specific selection. We investi-
gated the probiotic potential of Lactobacillus salivarius strains
isolated from fed pig feces for their use as porcine feed addi-
tives. Two methods were developed that simulated the pig
gastrointestinal (GI) tract and the intestinal epithelium, and
these were compared with human-based in vitro methods
and used for selecting porcine probiotics. Lactobacillus
salivarius strain LS6 was identified as a promising probiotic
strain for potential use as a porcine feed additive. This strain
prevented disruption of the epithelial integrity of pig small
intestine (PSI) cells by inhibiting the adherence of
enterotoxigenic Escherichia coli K88. It also showed high
survival rates in the in vitro pig GI tract model and good
adhesion to PSI cells. We propose that host target-specific
screening and validation methods are important tools in the
development of effective probiotic feed additives, and this
approach may support future-oriented agriculture.
Keywords Probiotics . Lactobacillus salivarius . Feed
additives . Porcine . Gastrointestinal tract . Adhesion ability
Introduction
Farm animals are affected by numerous environmental stress
factors. In particular, neonatal and weaned animals are suscep-
tible to physiological stresses (such as feeding practices, farm
management, and dietary needs), which can lead to the invasion
of pathogenic bacteria, potentially interfering with the composi-
tion of commensal microbes in the gastrointestinal (GI) tract
(Gaggìa et al. 2010; Yang et al. 2015). Gut microbial dysbiosis
is associated with various diseases and growth retardation in
young animals (Chaucheyras-Durand and Durand 2010). In
the 1940s, therefore, antibiotics were widely used, not only for
the prevention of bacterial infections‚ but also for the improve-
ment of production efficiency since the growth-promoting ef-
fects of sub-therapeutic levels of antibiotics were revealed
(Stokstad et al. 1950). However, the indiscriminate use of the
antibiotics led to the occurrence of antibiotic-resistant pathogen-
ic bacteria and the diffusion of resistance genes from animals to
humans (Berends et al. 2001). Consequently, the use of antibi-
otics as growth promoters (AGPs) in animal production has
been prohibited in the European Union since 2006 (EC 2001).
Instead, there has been increased focus on the development of
alternatives to AGPs as feed additives, such as probiotics, pre-
biotics, fermented liquid feed, essential oils, and organic acids.
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Pigs are an important, and economically significant, source of
livestock in theworld foodmarket, with 2 billion pigs being sup-
pliedeachyear.Thepigindustryhasbeenrepresentativeofbattery
farming andAGPuse; however, in recent times, alternative nutri-
tional strategies and feed additives have been explored (Pluske
2013). As a result, after the prohibition in 2006, the ratio of aver-
age loss to total distributionworldwide has been decreasedwith-
out the use of AGPs (USDA-FAS, PSDOnline). Probiotics, one
of thepromisingalternatives toAGPs in livestock, includingpigs,
have been reported to have growth-promoting effects that en-
hance animal production by increasing feed intake, the feed con-
version rate, and total body weight (Taras et al. 2007;
Chaucheyras-Durand and Durand 2010). In addition, probiotics
aiddigestiveprocesses inanimalsbysupporting theabsorptionof
certain essential nutrients (Yu et al. 2008).
In the present study, we had a dual objective, to compare
invitromodels of human- andpig-targetedGI tract environments
and intestinal epithelium, then to select and develop a putative
probiotic strain for use as a porcine feed additive. The require-
ments for effective probiotics to be used in livestock are that they
are of host-derived origin, show antimicrobial activity against
pathogenic bacteria, exhibit resistance and survival within GI
tracts, and are able to adhere to intestinal epithelial cells (de
Lange et al. 2010). However,many of the probiotic strains previ-
ously used as AGP alternatives were isolated from humans and
verified by human-based in vitro screeningmethods,whichwere
insufficient to reflect the physiology, immune system, and GI
microbial community of the host animal (Vlasova et al. 2016;
Gaggìaet al. 2010;deLangeetal. 2010).There is thereforeaneed
for a host target-specific probiotic strain, screened by appropriate
in vitro methods, that would potentially show enhanced in vivo
efficacy when administered to livestock as a feed additive. The
genus Lactobacillus is a strong candidate as probiotic bacteria.
This organism is a significant commensal of the normal gut mi-
crobiotaofmammalsandpredominantat theearlystageofpiggut
microflora construction (Naito et al. 1995; Richards et al. 2005).
Oneof thedominant species,Lactobacillus salivarius, frequently
isolated from theGI tracts of humans and pigs‚ has been reported
as a putative probiotic species due to its ability to exhibit antimi-
crobial activity, produce short chain fatty acids, attenuate inflam-
matory conditions, and modulate gut microbiota (Neville and
O’Toole 2010; Messaoudi et al. 2013). Therefore, in this study,
we investigated the probiotic properties and functional character-
istics of Lactobacillus salivarius strains isolated from fed pig
feces for their use as porcine feed additives.
Materials and methods
Strains and culture conditions
Bacterial strains were initially isolated from fed pig feces by
analysis of the physiological traits of lactic acid bacteria (i.e.,
Gram-positive, catalase negative, and rod shaped). The isolat-
ed strains were then further identified using the API 50 CHL
kit (BioMérieux, Marcy l’Etoile, France) and 16S rRNA se-
quencing. The amplification of 16S rRNA gene of the strains
was conducted with two reactions by PCR using primers 27F
5′ (AGA GTT TGA TCM TGG CTC AG) 3′ and 1492R 5′
(TAC GGY TAC CTT GTTACG ACT T) 3′. The PCR prod-
ucts were sequenced bi-directionally at Macrogen Corporation
(Seoul, Korea). Five representative colonies, all identified as
Lactobacillus salivarius, were selected based on the fact that
they showed comparatively high growth rates. Additionally,
Lactobacillus rhamnosusGG (ATCC 53103), which originated
from a healthy human intestine, was used as a positive
control. The pure cultures were maintained in de Man,
Rogosa and Sharpe (MRS) broth (Difco, Detroit, MI, USA)
and stored at −80 °C in MRS broth with 20 % (v/v) sterile
glycerol. Experiments performed under anaerobic conditions
used an anaerobic chamber (Coy Laboratory Products, Ann
Arbor, MI, USA) with an atmosphere consisting of 5 % CO2,
10 % H2, and 85 % N2.
Susceptibility to antibiotics
The minimum inhibitory concentrations (MICs) for selected
antibiotics were determined using a modification of the broth
microdilution susceptibility method for Lactobacillus spp.
specified in the National Committee for Clinical and
Laboratory Standards Institute guidelines (NCCLS 2010).
All strains were incubated for 18 h at 37 °C, and then diluted
to an optical density of 0.3 at 600 nm with a double-enriched
concentration of MRS medium. Double concentrations of the
antimicrobial agents were added to a 96-well microplate as a
two-fold serial dilution. The microbiological cut-off values
(mg/L) of antibiotics were derived from the European Food
Safety Authority guidelines (EFSA 2012).
Biogenic amine production, hemolytic and gelatinase
activity
According to the method of Bover-Cid and Holzapfel (1999),
biogenic amine production was analyzed in the isolated strains
for 4 days at 37 °C under aerobic and anaerobic conditions.
Enterococcus faecalis ATCC 29212 was used as a positive
control. The hemolytic and gelatinase activities of the strains
were also determined (Birri et al. 2013). Staphylococcus
aureus ATCC 25923 and Enterococcus faecalis ATCC
29212 were used as positive controls, respectively.
Fermentative and enzymatic profiling
Carbohydrate fermentation and metabolic end products were
determined using API 50 CHL and API ZYM kits
(BioMérieux), respectively. Strains were prepared at 2.0
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McFarland concentrations, inoculated into API 50 CH test
strips, and incubated at 37 °C for 48 h. For enzymatic profil-
ing, all strains were diluted to 5.0–6.0 McFarland with API
suspension medium, inoculated into API ZYM test strips, and
then incubated at 37 °C for 4 h. After the addition of one drop
of ZYM reagent, A and Bwere serially added to each strip and
incubated for 5 min, allowing colorimetric analysis to be
performed.
Acid and bile tolerance
All strains were propagated in MRS broth for 16 h at 37 °C
under anaerobic conditions. The cultures were washed and
inoculated into 30 ml of MRS broth with the pH adjusted to
2, 2.5, 3, 3.5, and 4 with 1 NHCl. The samples were incubated
at 37 °C under anaerobic conditions for 2 h, and the number of
viable (cfu ml−1) were counted and compared with the initial
counts (Hyronimus et al. 2000). Bile tolerance of the
Lactobacillus strains was determined by inoculating 5 % of
the washed cells into 30 ml of MRS broth supplemented with
0.1, 0.2, 0.3, and 0.5 % (w/v) bovine bile (Sigma-Aldrich, St.
Louis, MO, USA) and incubating at 37 °C anaerobically for
3 h. The optical densities were detected every hour
(Raghavendra and Halami 2009).
BSH activity
Bile salt deconjugation activity was screened using a previ-
ously reported method (du Toit et al. 1998) with some modi-
fications. Test strains were incubated for 18 h and spotted onto
MRS agar supplemented with 0.5 % (w/v) sodium salt of
taurodeoxycholic acid (Sigma) and 0.37 g l−1 CaCl2. Plates
were incubated at 37 °C for 3 days in an anaerobic chamber.
The bile salt hydrolase (BSH) activity was semiquantified by
measuring the diameter of the precipitation zones. This assay
was conducted in duplicate.
Antimicrobial activity
The antimicrobial activity of the strains was determined
using the modified agar diffusion method described by
Schillinger and Lücke (1989). The indicator stains used
in this test were Escherichia coli K88, Enterococcus
faecalis ATCC 29212, Listeria monocytogenes KCTC
13064, and Listeria innocua ATCC 33090. Briefly, station-
ary phase cells of the Lactobacillus and indicator strains
were collected by centrifugation at 9500×g for 10 min. The
cells were washed and diluted to a density of approximate-
ly 1 × 108 cfu ml−1. The pathogens were spread on MRS
agar plates using a sterilized swab. Sterilized disks were
placed in the plates using a disk dispenser (Oxoid,
Cambridge, UK), and 10 μl of Lactobacillus cell suspen-
sion was inoculated onto the disk. After incubation for 24 h
at 37 °C under aerobic or anaerobic conditions, the diam-
eter of the zone of inhibition was measured in centimeters.
Inhibition of pathogen adherence to PSI cells
The pig small intestinal cell line PSI was kindly provided
by Professor Dr. Avrelija Cencič (Department of
Microbiology, University of Maribor, Slovenia). PSI cells
were seeded at a density of 1 × 105 cells/cm2 per 12-mm
membrane Transwell insert with a seeding area of
1.12 cm2 and a pore size of 0.4 μm (Corning, Acton,
MA, USA). The enterotoxigenic Escherichia coli
(ETEC) K88 was obtained from the culture collection of
the College of Veterinary Medicine Laboratory, Seoul
National University, South Korea. Escherichia coli K88
was co-cultured with Lactobacillus strains to observe both
the change in the transepithelial electrical resistance
(TEER) and bacterial adherence on PSI cells. The
Lactobacillus strains and Escherichia coli K88 were prop-
agated at a concentration of 1 × 107 and 5 × 106 cfu ml−1,
respectively. Then, 250 μl of each Lactobacillus strain
was mixed with the same volume of ETEC K88 (total
volume 0.5 ml), and the mixtures were inoculated onto
pregrown PSI Transwell inserts. During incubation at
37 °C in a 5 % CO2 atmosphere, the TEER was detected
using a Millicell-ERS electrode (Millipore, Bedford, MA,
USA) hourly, and three wells for each sample were
washed and detached from the Transwell after 2.5 h.
The adherence assay was conducted as described for the
adhesion method below (Anderson et al. 2010). To differ-
entiate and enumerate Lactobacil lus strains and
Escherichia coli K88, MRS and Salmonella-Shigella agar
(Difco) were used selectively.
In vitro human and pig GIT simulation models
The gastrointestinal tract (GIT) model consists of three
digestive compartments divided into the mouth, stomach,
and small intestine. The pig GIT simulation model was
based on the human model (Oomen et al. 2003) with
modifications to the mucin concentration, pH, and incu-
bation time, to optimize it more closely to the physiolog-
ical traits of pigs (Kararli 1995; Merchant et al. 2011).
The modified factors and the constituents and concentra-
tions of the various synthetic juices are listed in Table 1.
In addition, each artificial juice was mixed and preheated
to 37 °C just before use, and all chemicals were purchased
from Sigma-Aldrich. To simulate the in vitro digestion of
humans and pigs, 7 ml of the Lactobacillus salivarius
strains (1 × 109 cfu ml−1) were centrifuged and resuspend-
ed in 1 ml of 1× phosphate buffered saline, then mixed
with 6 ml of saliva (pH 6.5). After 5-min incubation,
12 ml of gastric juice was added and incubated for 2 h.
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Then, 12 ml of duodenum juice, 6 ml of bile acid, and
2 ml of NaHCO3 were added, followed by further incu-
bation for 2 and 5 h, to reflect the time taken for ingesta
to pass through human and pig intestines, respectively.
Incubation was performed at 37 °C in an anaerobic cham-
ber and centrifuged at 50 rpm to simulate peristaltic con-
tractions. Test strains were harvested at three time points
to simulate the mouth, stomach, and small intestine. The
harvested cells were serially diluted and plated onto MRS
agar. Experiments were carried out in triplicate and re-
peated three times.
Adhesion ability to Caco-2 and PSI cells
Caco-2 and PSI cells were grown on Dulbecco’s modified
Eagle’s medium (DMEM, Gibco, Carlsbad, CA, USA)
supplemented with 10 % fetal bovine serum (FBS,
Gibco), L-glutamine (2 mmol l−1), 100 μg streptomycin
ml−1, 100 U penicillin ml−1, and 0.25 μg amphotericin B
ml−1 (Gibco) at 37 °C in a 5 % CO2 atmosphere. For the
adhesion assay, cells were seeded in 12-well plates at a
concentration of 2.5 × 106 cfu ml−1 and incubated until
confluence for 21 days prior to the assay. The cell culture
medium was changed on alternate days with preheated
fresh medium, and the cells were washed with DMEM
without antibiotics prior to use.
Overnight cultures of the Lactobacillus salivarius
strains grown in 90 % DMEM supplemented with 2 %
FBS and 10 % MRS were harvested, resuspended with
preheated DMEM without antibiotics, and adjusted to an
optical density of 1.0 at 600 nm (approximately
1 × 108 cfu ml−1). A 1-ml aliquot of the bacterial
DMEM culture was inoculated into each well of the cell
culture plate. The plates were incubated at 37 °C for
90 min in a 5 % CO2 atmosphere. Then, each well
was washed twice with 1 × phosphate buffered saline
and cell layers with attached bacteria were lysed with
1 ml of 0.1 % Trypsin-EDTA solution (Gibco). The
number of viable bacterial cells was enumerated using
the serial dilution method from the initial and the de-
tached lysates on MRS agar (Schillinger et al. 2005).
Experiments were carried out in triplicate and repeated
three times.
Statistical analysis
Data were analyzed using the Student’s t test to evaluate dif-
ferences in discrete variables between the samples.
Table 1 The constituents, chemicals, and conditions used for the human and porcine in vitro gastrointestinal tract (GIT) models
Inorganic solution Organic solution Digestive constituents Human & Pig factors
Mouth 
(saliva)
KCl 89.6 g l-1
NaCl 175.3 g l-1
KSCN 20 g l-1
NaH2PO4 88.8 g l
-1
Na2SO4 57 g l
-1
NaOH 40 g l-1
urea 25 g l-1
α-amylase
Uric acid
Initial pH: 6.5 ± 0.2
Incubation time: 5 min




KCl 89.6 g l-1
NaCl 175.3 g l-1
NaH2PO4 88.8 g l
-1
NH4Cl 30.6 g l
-1
CaCl2·2H2O 22.2 g l
-1
HCl 37% g g-1
urea 25 g l-1
glucose 65 g l-1
glucuronic acid 2 g l-1
glucoseamine 





Total pH: 3.2 ± 0.2
Incubation time: 2 h
Mucin: 33 g l-1
Pig
Total pH: 4.4 ± 0.2
Incubation time: 2 h




KCl 89.6 g l-1
NaCl 175.3 g l-1
NaHCO3 84.7 g l
-1
KH2PO4 8 g l
-1
MgCl2 5 g l
-1
HCl 37% g g-1
KCl 89.6 g l-1
NaCl 175.3 g l-1
NaHCO3 84.7 g l
-1
HCl 37% g g-1
urea 50 g l-1







Total pH: 6.8 ± 0.2
Incubation time: 2 h
Pig
Total pH: 6.5 ± 0.2
Incubation time: 5 h
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Accession numbers
The nucleotide sequences of 16S rRNA genes have been
deposited at the GenBank database under the accession
numbers KX266895-KX266899 for the representative
five strains studied; Lactobacillus salivarius strains
LS1, LS3, LS4, LS6, and LS8. Lactobacillus salivarius
strain LS6 isolated from fed pig feces has been deposited
at Korean Collection for Type Cultures (KCTC),
Jeollabuk-do, South Korea, under the accession number
KCTC 18458P.
Results
Characterization of probiotic properties
Safety assessment
The MIC values of the five selected strains were
screened for seven antibiotics. Based on the overall bi-
ological breakpoints, strains LS6 and LS8 were found to
be susceptible to all of the antibiotics tested, except
vancomycin. On the other hand, resistance to erythro-
mycin was detected in strains LS3 and LS4, and resis-
tance to clindamycin was detected in strains LS1, LS3,
and LS4 (Table 2). None of the isolates exhibited bio-
genic amine production or hemolytic activity. In addi-
tion, gelatinase activity in the test strains was lower
than in the positive control, with the exception of strain
LS1 under anaerobic conditions (Table 3).
Metabolic profiles
The pig-derivedLactobacillus salivarius strains showed identical
patterns of fermentation, with the exception of strain LS1 that did
not use arbutin (Fig. 1). On testing enzymatic activity, all strains
showed strong leucine arylamidase and β-galactosidase activity
and moderate activities for six other enzymes (Fig. 1).
Acid and bile tolerance, bile salt hydrolase activity,
and antimicrobial activity
All five Lactobacillus salivarius strains demonstrated toler-
ance to acidic conditions (i.e., pH 3). After 2 h of incubation
in MRS medium at pH 3, the survival rates of Lactobacillus
salivarius strains LS3 and LS6 were 85.88 and 95.17 %, re-
spectively. The LGG positive control showed a survival rate
of 77.3 %. Although all of the test isolates showed lower
growth rates than LGG (only 30.4 % of the slope) in MRS
medium supplemented with 0.3 % (w/v) bovine bile, they
were able to grow under conditions of bile salt stress
(Table 4). In addition, the Lactobacillus salivarius strains ex-
hibited high BSH ability, as shown by precipitation zones in
the BSH agar plate (Table 4).
The results of the agar diffusion assay demonstrated the
antagonistic activities of the washed cells of all of the test
Table 2 Minimum inhibitory concentrations (μg ml−1) of antibiotics to
Lactobacillus salivarius strains
AMP VAN GEN CHL STR ERY CLI
L. salivarius
LS1 2 >512 64 2 128 1 2
LS3 2 >512 64 4 256 >8 >8
LS4 1 >512 128 4 512 >8 >8
LS6 1 >512 128 2 256 1 0.5
LS8 2 >512 128 2 256 1 0.25
Suggested breakpoints for L. salivarius
NCCLS ≥16 ≥16 ≥8 ≥2
EFSA 4 n.r. 16 4 64 1 1
SCAN 2 4 1 16 16 4
Danielsen and
Wind (2003)
4 4 256 16 >256 1 2
AMP ampicillin, VAN vancomycin,GEN gentamicin,CHL chloramphen-
icol, STR streptomycin, ERY erythromycin, CLI clindamycin, n.r. not
required
Table 3 Safety assessment of the metabolic end products of the












+ + n.r. n.r. 1.1 ± 0.0 1.0 ± 0.0
S. aureus
ATCC 25923
n.r. n.r. + + n.r. n.r.
L. salivarius
LS1 − − − − 0.9 ± 0.1 1.0 ± 0.0
LS3 − − − − 0.9 ± 0.0 0.8 ± 0.0
LS4 − − − − 0.8 ± 0.0 0.8 ± 0.0
LS6 − − − − 0.8 ± 0.0 0.8 ± 0.0
LS8 − − − − 0.7 ± 0.0 0.7 ± 0.0
n.r. not required, AR, ANAR 37 °C aerobic and anaerobic conditions,
respectively
a Average diameter (cm) values ± the standard deviation (n = 2)
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strains against Escherichia coli K88 and Listeria innocua
ATCC 33090 under both aerobic and anaerobic conditions,
whereas the strains only inhibited the growth of Listeria
monocytogenes KCTC 13064 under aerobic conditions.
None of the test strains exhibited a significant inhibitory effect
on Enterococcus faecalis ATCC 29212 (Table 4). Bacteriocin
production was also investigated using cell-free supernatant
adjusted to pH 6.5 with 1 N NaOH, but no bacteriocin pro-
duction was detected in any of the Lactobacillus salivarius
strains. Moreover, cell-free supernatant that was not pH-
adjusted showed no significant antibacterial effect on any oth-
er indicator strains (data not shown).
Functionality in host target-specific models
Protection of epithelial cells
In a previous experiment, all Lactobacillus salivarius isolates
were screened in a TEER assay, and isolates LS4, LS6, and
LS8 were selected as having a positive effect on TEER mea-
surements (Fig. S1, Supporting Information). Lactobacillus
rhamnosus GG also showed a significant increase in the
TEER value to 172 % after 6-h incubation.
The co-culture of Escherichia coli K88 and test strain LS6
significantly increased the TEER value to 146 %, whereas
Fig. 1 Fermentative and
enzymatic profiling of selected
Lactobacillus salivarius strains
isolated from pig feces. The
colorimetric intensity is indicated
by color gradients: black
represents high activity, while
white represents no reaction. The
carbohydrates and enzymes for
which most strains did not react
are not shown
Table 4 Probiotic properties of Lactobacillus strains
Bacterial culture Acid tolerancea (%) Bile tolerance
(% slopeb)
BSH activity Diameter of the zone of inhibitionc
E. c E. f L. m L. i
0 h 2 h AR ANAR AR ANAR AR ANAR AR ANAR
L. salivarius
LS1 100 66.95* 18.4 + + ++ (+) − ++ − ++ +++
LS3 100 85.88 6.6 + + + − − ++ − + ++
LS4 100 50.11** 12.0 + + ++ − − ++ − ++ ++
LS6 100 95.17* 15.8 + + ++ − − ++ − +++ ++
LS8 100 59.29* 10.8 + + ++ (+) − ++ − ++ ++
L. rhamnosus
GG 100 77.30 30.4 − + ++ − − ++ − ++ ++
L. rhamnosus GG, a commercial lactic acid bacteria, was used as a standard reference culture
E. c Escherichia coliK88, E. f Enterococcus faecalisATCC 29212, L. m Listeria monocytogenesKCTC 13064, L. i Listeria innocuaATCC 33090, AR,
ANAR 37 °C aerobic and anaerobic conditions, respectively, BSH bile salt hydrolase
a Cell survival at pH 3.0. Significance is indicated as follows: *P ≤ 0.05; **P ≤ 0.01, compared to the survival of LGG
b Slope; (x, y) = (time, OD600 value) of 0–3 h in MRS broth supplemented with 0.3 % bovine bile. r
2 = 0.97 ± 0.02
c +++, >3 cm; ++, >2 cm; +, >1 cm; (+), < 1 cm; −, no clear zone
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co-incubation of Escherichia coli K88 with other
Lactobacillus strains, even with LGG, reduced the TEER val-
ue of PSI cells (Fig. 2a). After 2.5 h of treatment with ETEC
K88 and test strain LS6, ETEC showed an adherence rate of
24 % compared with 58.9 % for strain LS6 strain (Fig. 2b, c).
ETECK88 binding was not affected by either the LGG or LS4
test strains (Fig. 2b), and the TEER of PSI cells was signifi-
cantly reduced by co-culturing ETEC with LS4 (Fig. 2a).
Strain LS8 reduced ETEC adherence to 29 % (Fig. 2b), with
LS8 adherence being even lower at 25.1 % (Fig. 2c); more-
over, disruption of the integrity between PSI cells was ob-
served by a change in the TEER value (Fig. 2a).
Survival in the GIT
The simulated pig GIT model was based on the human GIT
model with modifications in the pH, incubation time, and
amount of mucin (Table 1). All strains showed strain-
specific survival compared with the control (strain LGG) in
both GIT models (Fig. 3). Strains LS1 and LS3 showed lower
survival rates than did control strain LGG under both GIT
models, whereas strain LS4 showed a survival rate increase
of about 0.86-fold in the human GITmodel compared with the
1.4-fold in the pig GIT model. By contrast, the survival of
strain LS8 was increased 1.6-fold and 0.3-fold in the human
and pig GIT models, respectively. Lactobacillus salivarius
LS6 exhibited high tolerance and adaptation in response to
both GITs but was more sensitive to pig GIT stress (Fig. 3b).
Adhesion ability to epithelial cells
The adhesion ability of all strains was similar to each cell line
compared with control strain LGG, which showed 5.1 and
15.5 % adhesion to Caco-2 and PSI cells, respectively
(Fig. 4a, b). With the exception of strain LS8, all of the test
strains were observed to be lower than 0.3-fold (1.6 % adher-
ence) to Caco-2 cells and at least 0.5-fold (8 % adherence) to
PSI cells, compared with the control strain LGG. The relative
adhesion ability of strain LS8 was similar to that of control
strain LGG to both Caco-2 and PSI cells.
Discussion
In the present study, we identified the probiotic properties of
Lactobacillus salivarius strains isolated from fed pig feces,
which could potentially be used as feed additives for porcine.
Recently, increased research into the development of
probiotics for humans and animals confirmed that probiotic
action may be influenced by the host (Vlasova et al. 2016).
Therefore, we developed and evaluated pig-based screening
models that differ from existing human-based methods.
Differences were observed in the viability and adhesive ability
of strains under porcine and human conditions.
Prior to these studies, isolates have been assessed for their
safety and functionality as probiotics. One of the safety con-
cerns regarding probiotics is the existence of antibiotic resis-
tance. According to the National Committee for Clinical and
Laboratory Standards Institute guidelines (NCCLS 2010) and
Fig. 2 Change in TEER across confluent PSI cells and bacterial
adherence to PSI cells during co-culturing of Lactobacillus strains and
enterotoxigenic Escherichia coli (ETEC) K88. The graphs (a) represent
TEER values (% of initial value, 0 h) of PSI cells after 6 h of co-incuba-
tion of Lactobacillus strains and Escherichia coli K88. Adherence was
investigated 2.5 h after bacterial treatment. b Binding ability of ETEC
K88 to PSI cells. c Binding ability of human-derived LGG strain and pig-
derived Lactobacillus salivarius strains. The data represent the means and
standard errors of three replicates. Significance is indicated as follows:
*P ≤ 0.05; **P ≤ 0.01
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the European Food Safety Authority (EFSA 2012)
breakpoints, five Lactobacillus salivarius strains isolated from
pig feces were found to be resistant to the antibiotics tested,
with the exception of ampicillin (Table 2). In addition, when
compared with the microbiological breakpoints proposed by
the Scientific Committee for Animal Nutrition (SCAN 2002),
all isolates showed high MIC values for vancomycin, genta-
micin, and streptomycin. However, some Lactobacillus spp.
are considered to be intrinsically resistant to vancomycin
(NCCLS 2010), and there are no well-defined standards for
the MIC ranges and the MIC determination methods for
Lactobacillus spp. (SCAN 2002). Moreover, the MIC values
of microorganisms depend on the type of test medium used. In
this study, MRS medium was employed because the five iso-
lates tested could not grow in cation-adjusted Mueller-Hinton
II broth supplemented with 2.5 % (v/v) lysed horse blood, the
standard medium used for Lactobacillus spp. as suggested by
the NCCLS (2010), EFSA (2012), and SCAN (2002).
Therefore, breakpoints suggested by the NCCLS, EFSA,
and SCAN were insufficient to determine the susceptibility
of these strains, so MIC breakpoints based on MRS medium,
as suggested byDanielsen andWind (2003), were additionally
applied. As a result, it could be considered that Lactobacillus
salivarius strains LS6 and LS8 are safe against antibiotic re-
sistance transfer for use in livestock.
Biogenic amines are nitrogenous substances, mainly pro-
duced by the decarboxylase of lactic acid bacteria during im-
proper fermentation. The risk of biogenic amines to humans
has been reported in several studies (Bover-Cid and Holzapfel
1999; Ladero et al. 2010; EFSA 2011). However, there is little
information regarding the influence of biogenic amines on pig
health, but it has been reported that high levels of biogenic
amines in liquid feed reduced feed intake and growth perfor-
mance of pigs (Pedersen 2001; Brooks 2003). According to
our result, the pig-derived strains did not produce biogenic
amines from the four amino acids tested (Table 3), and thereby
appear safe for use as additives to porcine feed containing high
levels of protein. Furthermore, none of the tested isolates in-
dicated hemolytic or gelatinase activity perceived as potential
virulence factors in food and feed (Table 3) (Oakey et al. 1995;
Bernardeau et al. 2006).
Potentially detrimental enzyme activities are another im-
portant safety issue to be considered regarding probiotics, in
particularβ-glucosidase andβ-glucuronidase are known to be
Fig. 3 The viability of
Lactobacillus strains on passing
through the in vitro GIT model,
simulating a the human and b the
pig GI tract. Relative survival rate
was calculated as a fold change
comparedwith LGG survival. See
also Table 1 for information on
the factors modified between the
porcine and human GIT models.
The data represent the means and
standard errors of three replicates.
Significance is indicated as
follows: *P ≤ 0.05; **P ≤ 0.01;
***P ≤ 0.001
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carcinogenic enzymes in the intestine, whereas β-
galactosidase is beneficial for the relief of lactose intolerance
in animals (Lee et al. 2008; Bujnakova et al. 2013). The
Lactobacillus salivarius strains tested in this study showed
high β-galactosidase activity (Fig. 1).
According to Lähteinen et al. (2010), Lactobacillus
salivarius isolates originating from porcine intestines were
generally intolerant to pH 2. Our Lactobacillus salivarius
strains could survive at pH 3 (Table 4), and Lactobacillus
salivarius LS6 was even able to survive at a rate over 55 %
at pH 2 (data not shown).
Bile acids are metabolic end products synthesized from
cholesterol in the liver that are conjugated with glycine or
taurine and then secreted into the duodenum through the gall
bladder at an average daily volume of 400–800 mg (Tsai et al.
2011). The conjugated bile acids can dissolve bacterial mem-
branes, thus to survive bacteria need to tolerate high levels of
bile acids in the GI tract. We found that Lactobacillus
salivarius strains were able to tolerate and grow at 0.5 % bile
salt concentrations (data not shown). Furthermore,
deconjugation activity was shown for all Lactobacillus
salivarius strains in a strain-specific manner, whereas no
BSH activity was observed for Lactobacillus rhamnosus
strain GG (Table 4). Conjugated bile acids in the small intes-
tine can be deconjugated and converted to secondary bile
acids by bacterial BSH enzyme, which is related to the host
serum cholesterol-lowering effect of the enterohepatic circu-
lation (Corzo and Gilliland 1999). Thereby, the BSH activity
of probiotics can contribute to the health benefits of animal
products.
Enterotoxigenic Escherichia coli (ETEC) K88 is a major
enteropathogen in neonatal and weaned pigs, and their fimbri-
al adherence and production of enterotoxins within the pig
intestine can cause diarrheal illness and even death (Francis
2002). All of the strains tested in this study inhibited the
growth of ETEC K88 under both aerobic and anaerobic con-
ditions, whereas they inhibited the growth of Listeria
monocytogenes KCTC 13064 under aerobic conditions only
(Table 4). This antagonistic effect was confirmed in the pig
small intestine cell line PSI (Fig. 2). TEER and adhesion as-
says indicated that when the tested lactobacilli were
co-cultured with ETEC K88, they inhibit ETEC K88 adher-
ence as well as attenuating disruption of the tight junctions
between PSI cells. Tight junctions are one of the mechanisms
Fig. 4 The relative adhesion
ability of Lactobacillus strains on
aCaco-2 and b PSI cells. Relative
adherence was calculated as a fold
change compared with LGG
adherence, which was 5.1 and
15.5 % on Caco-2 and PSI cells,
respectively. The data represent
the means and standard errors of
three replicates. Significance is
indicated as follows: **P ≤ 0.01;
***P ≤ 0.001
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for sustaining gut epithelium cell-cell adherence. Enteric infec-
tions by bacteria such as Salmonella spp., Shigella spp.,
enterohemorrhagic Escherichia coli, and ETEC, lead to the
breakdown of tight junctions by type III secretion systems
and bacterial surface proteins, leading to increased cell
permeability and the penetration of bacteria across host
tissues (Ashida et al. 2011). Many reports suggest that probiotic
bacteria could not only improve the intestinal barrier func-
tion (Anderson et al. 2010) but also ameliorate the invasion of
enteropathogenic Escherichia coli and ETEC (Lodemann et al.
2015). In particular, weaned piglets commonly show symptoms
of gastroenteritis caused by ETEC K88, and pathogenicity was
alleviated by the use of probiotics as feed additives (Setia et al.
2009; Bhandari et al. 2010). Based on our findings, the
antipathogenic effect was related to competition for adherence
between Lactobacillus strains and ETEC. After co-culturing, the
adherence of ETEC K88 was inhibited by Lactobacillus
salivarius strains LS6 and LS8 (Fig. 2b), but strain LS8 did not
adhere well compared with strain LS6 (Fig. 2c). The results of
TEER assays indicated that this difference was caused by strain-
specific effects on the integrity of tight junctions (Fig. 2a).
Therefore, Lactobacillus salivarius LS6 may be effective in the
treatment of ETEC infection, and the results of this TEER com-
petition assay are useful in the selection of functional probiotics.
Humans and pigs are both monogastric organisms possessing
an oral cavity, stomach, and intestine. However, the
physiological traits of their GI tracts differ. Merchant et al.
(2011) reported that pigs have a longer gut (∼24 m; 2.4 cm/kg
body weight) compared with humans (8.9 m; 14 cm/kg body
weight). This difference in gut length affects the time taken by
ingesta, such as food/feed including probiotics, to pass through
the GIT; hence, in our model, wemodified the incubation time to
simulate the pig intestine.Moreover, there were differences in the
average pH values of the stomach and intestine depending on the
host (Table 1). In our investigations, when we applied human-
based criteria, a commercial probiotic Lactobacillus rhamnosus
GG was selected as a candidate feed additive, whereas
Lactobacillus salivarius LS4 was not selected (Fig. 3a).
However, Lactobacillus salivariusLS4 exhibited the highest sur-
vival rates under conditions of pig GI tract stress (Fig. 3b).
Lactobacillus salivarius LS8 could also be selected (Fig. 3a),
even though it showed the lowest survival rates in the pig GIT
model (Fig. 3b). These results indicate that human-based stress
tolerance screening methods are not always suitable for the de-
velopment of porcine probiotics. Although there is still scope for
improvement, our suggested in vitro porcine GIT simulation
model is effective for selecting probiotic candidates for pig-
targeted application.
The Caco-2 human colon adenocarcinoma cell line has been
widely used in adhesion assays for the identification of potential
probiotic lactic acid bacteria. However, these cells do not derive
from the small intestine; rather, they are a tumorigenic cell line
(Cencič and Langerholc 2010). Therefore, in this study, the pig-
derived non-carcinoma small intestine cell line PSI, established
by Cencič and colleagues (Gradisnik et al. 2006), was applied.
Only Lactobacillus salivarius LS8 was considered a probiotic
candidate based on the adhesion properties to Caco-2 cells
(Fig. 4a); however, all of the pig-derived isolates were considered
probiotic candidates based on their adhesion properties to PSI
cells (Fig. 4b). These findings highlight the inadequacies of
Caco-2 cells as an in vitro adhesionmodel withwhich to evaluate
the binding ability of strains for porcine.
In conclusion, we identified Lactobacillus salivarius strain
LS6 as a potential probiotic strain for use as a porcine feed
additive. Our findings confirm that potential probiotics should
be selected based on target host-specific criteria to ensure their
suitability and functionality in the intended host. Furthermore,
the scientifically validated in vitro methods presented here can
be used to replace animal testing experiments, thereby reduc-
ing costs and eliminating unnecessary suffering in line with
the Registration, Evaluation and Authorization of Chemicals
(REACH) regulations.
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